Home  >  Products  >  HSD17B8 (hydroxysteroid (17-beta) dehydrogenase 8 ) Blocking Peptide (the N terminal of HSD17B8)(100ug)
HSD17B8 (hydroxysteroid (17-beta) dehydrogenase 8 ) Blocking Peptide (the N terminal of HSD17B8)(100ug)

HSD17B8 (hydroxysteroid (17-beta) dehydrogenase 8 ) Blocking Peptide (the N terminal of HSD17B8)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-HSD17B8 Antibody (ARP62143_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62143
Size: 100ug
Weight: 29kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: In mice, the Ke6 protein is a 17-beta-hydroxysteroid dehydrogenase that can regulate the concentration of biologically active estrogens and androgens. It is preferentially an oxidative enzyme and inactivates estradiol, testosterone, and dihydrotestosterone. However, the enzyme has some reductive activity and can synthesize estradiol from estrone. The protein encoded by this gene is similar to Ke6 and is a member of the short-chain dehydrogenase superfamily. An alternatively spliced transcript of this gene has been detected, but the full-length nature of this variant has not been determined.
Alternative names: D6S2245E; FABG; FABGL; H2-KE6; HKE6; KE6; RING2; SDR30C1; dJ1033B10.9
See Full Product Listings >